title: Report of the American College of Cardiology (ACC) Scientific Sessions 2013, San Francisco--highlighting late-breaking trials.
abstract: The American College of Cardiology's (ACC) 62nd Annual Scientific Session was held at the Moscone Center, San Francisco, from March 9-11, 2013. The meeting focused on the "transformation of cardiovascular care, from discovery to delivery", featured over 20 late-breaking clinical trials and 2,000 abstracts. These sessions gave notable exposure and recognition of studies likely to significantly affect clinical practice. There were 21 trials scheduled for presentation in 5 featured Late-Breaking Clinical Trial sessions, but one, the PREVAIL trial, was not presented because of a failure to observe an embargo. I summarize and overview both the late-breaking trials presented at ACC 2013 and the PREVAIL trial.
authors.affiliation: Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan. yamadah@tokushima-u.ac.jp
authors.forename: Hirotsugu
authors.initials: H
authors.lastname: Yamada
mesh_terms: D002309:Cardiology; D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000628:therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D012955:Societies, Medical; D016896:Treatment Outcome